02.10.2017 • News

Praxair Shareholders Approve Merger with Linde

(c) Linde
(c) Linde

Praxair’s shareholders have overwhelmingly approved the proposed merger with Linde. At a special shareholders meeting on Sept. 27, about 83% of the total issued and outstanding shares of Praxair common stock was in favor of the deal, exceeding the required majority and representing approximately 99% of the total votes cast.

“Today’s vote confirms that Praxair shareholders support this transaction and brings us one step closer to creating a world-class leader in the industrial gas industry,” said Steve Angel, Praxair’s chairman and CEO.

The approval is an essential step toward combining the two major industrial gases group under new holding company, Linde plc. However, 75% of Linde’s shareholders must tender their stock to the new company by Oct. 24 for the merger to go ahead, as well as obtaining antitrust approvals and fulfilling other customary closing conditions.

Praxair and Linde expect the transaction to complete in the second half of 2018.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read